Related Experiment Video
Updated: Aug 6, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
PACT Inhibits Malignant Biological Behavior of Ovarian Cancer Cells by Regulating TERT Expression
Xuemei Yang1,2, Qian Zhang3, Xiaofeng Yang1
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
p53-associated cellular protein-testes derived (PACT) promotes ovarian cancer (OC) progression by inhibiting ferroptosis. Targeting PACT may offer a new therapeutic strategy for OC by reactivating ferroptosis and suppressing tumor growth.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ovarian cancer (OC) is a deadly malignancy with few effective treatments.
- The role of p53-associated cellular protein-testes derived (PACT) in OC and ferroptosis is not well understood.
Purpose of the Study:
- To investigate the function of PACT in OC cell proliferation, migration, invasion, and ferroptosis.
- To elucidate the molecular mechanisms underlying PACT's role in OC progression, focusing on the Keap1-Nrf2-TERT pathway.
Main Methods:
- siRNA-mediated knockdown and overexpression of PACT in OC cell lines (A2780, OVCAR-3).
- Assays for cell proliferation (CCK-8), migration/invasion (Transwell), and ferroptosis (cell death, iron, MDA, ROS, SLC7A11, GPX4).
- Co-immunoprecipitation, ubiquitination assays, subcellular localization analysis, and in vivo xenograft models.
Main Results:
- PACT knockdown inhibited OC cell proliferation, migration, and invasion while promoting ferroptosis.
- PACT promotes OC progression by suppressing ferroptosis via the Keap1-Nrf2-TERT pathway, enhancing TERT expression and telomerase activity.
- PACT facilitates Keap1 ubiquitination and degradation, promoting Nrf2 nuclear translocation and subsequent TERT upregulation.
Conclusions:
- PACT drives ovarian cancer progression by suppressing ferroptosis and promoting malignant phenotypes through the Keap1-Nrf2-TERT axis.
- Targeting PACT is a potential therapeutic strategy for ovarian cancer.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
